On September 2nd, HBM Holdings-B issued a supplementary announcement to provide further details on the changes to its directors and authorized representatives that were disclosed on August 27th. The announcement confirms that Dr. Rong Yiping resigned as an executive director to dedicate more time and energy to his other personal business affairs.
According to the earlier announcement, the personnel changes took effect on August 27th. Dr. Rong Yiping resigned as an executive director and also ceased to serve as an authorized representative under Rule 3.05 of the Hong Kong Listing Rules. Concurrently, Chen Youchen and Liu Yi were appointed as executive directors, with Chen Youchen taking over the role of authorized representative.
Dr. Rong previously confirmed that he has no disagreement with the board of directors and that there are no other matters requiring the attention of shareholders or the Hong Kong Stock Exchange. The supplementary announcement underscores that all information contained in the original announcement from August 27th remains complete and valid, and that both announcements should be read in conjunction with each other.
The announcement also outlines the current composition of the board. The executive directors are Dr. Wang Jinsong, Mr. Chen Youchen, and Dr. Liu Yi, while the independent non-executive directors include Dr. Robert Irwin Kamen, Dr. Ye Xiaoping, Dr. Albert R. Collinson, and Ms. Chen Weiwei. All arrangements related to these personnel adjustments have been fully implemented, marking the completion of the board's structural update.
Comments